These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32496683)

  • 1. [Actual treatments of psoriasis : from etanercept to anti-IL17 and anti-IL23 antagonists].
    Libon F; Lebas E; El Hayderi L; De Schaetzen V; Dezfoulian B; Nikkels AF
    Rev Med Liege; 2020 May; 75(5-6):376-381. PubMed ID: 32496683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients.
    Libon F; Lebas E; De Schaetzen V; Sabatiello M; De Schepper S; Nikkels AF
    Expert Rev Clin Immunol; 2021 Sep; 17(9):947-955. PubMed ID: 34328370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic response modifiers and pediatric psoriasis.
    Bellodi Schmidt F; Shah KN
    Pediatr Dermatol; 2015; 32(3):303-20. PubMed ID: 25727936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
    Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic drug survival in Israeli psoriasis patients.
    Shalom G; Cohen AD; Ziv M; Eran CB; Feldhamer I; Freud T; Berman E; Oren S; Hodak E; Pavlovsky L
    J Am Acad Dermatol; 2017 Apr; 76(4):662-669.e1. PubMed ID: 28038888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis.
    Gibellini L; De Biasi S; Bianchini E; Bartolomeo R; Fabiano A; Manfredini M; Ferrari F; Albertini G; Trenti T; Nasi M; Pinti M; Iannone A; Salvarani C; Cossarizza A; Pellacani G
    PLoS One; 2016; 11(12):e0167757. PubMed ID: 27936119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept for patients with psoriasis who did not respond or who lost their response to adalimumab or infliximab.
    Bissonnette R; Maari C; Barber K; Lynde CW; Vender R
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1576-81. PubMed ID: 25600828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials.
    Papp KA; Yang M; Sundaram M; Jarvis J; Betts KA; Bao Y; Signorovitch JE
    Value Health; 2018 Jan; 21(1):1-8. PubMed ID: 29304933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
    Garber C; Creighton-Smith M; Sorensen EP; Dumont N; Gottlieb AB
    J Drugs Dermatol; 2015 Aug; 14(8):881-6. PubMed ID: 26267734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
    Pirmit S; Onsun N; Su O; Ozkaya DB
    G Ital Dermatol Venereol; 2017 Apr; 152(2):126-131. PubMed ID: 28166613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological therapies in moderate and severe psoriasis: perspectives and certainties.
    Constantin MM; Poenaru E; Constantin T; Poenaru C; Purcarea VL; Mateescu BR
    J Med Life; 2014; 7 Spec No. 2(Spec Iss 2):15-7. PubMed ID: 25870666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: state of the art 2013.
    de la Brassinne M; Nikkels A
    Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF inhibitors for psoriasis.
    Chima M; Lebwohl M
    Semin Cutan Med Surg; 2018 Sep; 37(3):134-142. PubMed ID: 30215629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study.
    Di Lernia V; Ficarelli E; Lallas A; Possemato N; Chiarolanza I; Salvarani C
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2262-3. PubMed ID: 24911670
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of biologic therapies in psoriasis vulgaris.
    Mala R; Fida M; Jorgaqi E; Vasili E
    Dermatol Ther; 2019 Jul; 32(4):e12936. PubMed ID: 30983095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cost Effectiveness of Treatments of Psoriasis with a PASI 75 and one Period of 12 Weeks].
    Alfageme Roldán F; Bermejo Hernando A; Calvo González JL; Marqués Sánchez P
    Rev Esp Salud Publica; 2016 Apr; 90():E15. PubMed ID: 27073006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
    Busard CI; Cohen AD; Wolf P; Gkalpakiotis S; Cazzaniga S; Stern RS; Hutten BA; Feldhamer I; Quehenberger F; Lichem R; Kojanova M; Adenubiova E; Addis A; Naldi L; Spuls PI
    J Eur Acad Dermatol Venereol; 2018 Feb; 32(2):245-253. PubMed ID: 28898541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.